These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 24225272

  • 1. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
    Hird BE, Tetlow L, Tobi S, Patel L, Clayton PE.
    Arch Dis Child; 2014 Feb; 99(2):158-64. PubMed ID: 24225272
    [Abstract] [Full Text] [Related]

  • 2. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.
    Votava F, Török D, Kovács J, Möslinger D, Baumgartner-Parzer SM, Sólyom J, Pribilincová Z, Battelino T, Lebl J, Frisch H, Waldhauser F, Middle European Society for Paediatric Endocrinology -- Congenital Adrenal Hyperplasia (MESPE-CAH) Study Group.
    Eur J Endocrinol; 2005 Jun; 152(6):869-74. PubMed ID: 15941926
    [Abstract] [Full Text] [Related]

  • 3. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
    Fingerhut R.
    Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
    [Abstract] [Full Text] [Related]

  • 4. [Multicenter investigation on the impact of newborn infants' gestational age and birth weight on the level of 17α-hydroxyprogesterone].
    Zhang Q, Wang B, Chen Y, Jiang D, Chen Y.
    Zhonghua Er Ke Za Zhi; 2014 Sep; 52(9):706-9. PubMed ID: 25476436
    [Abstract] [Full Text] [Related]

  • 5. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
    Varness TS, Allen DB, Hoffman GL.
    J Pediatr; 2005 Oct; 147(4):493-8. PubMed ID: 16227036
    [Abstract] [Full Text] [Related]

  • 6. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants.
    Nordenström A, Wedell A, Hagenfeldt L, Marcus C, Larsson A.
    Pediatrics; 2001 Oct; 108(4):E68. PubMed ID: 11581476
    [Abstract] [Full Text] [Related]

  • 7. Monitoring congenital adrenal hyperplasia using blood spot 17-hydroxyprogesterone assay.
    Santos CM, Abad LR, Cua SC, Domingo CF.
    Southeast Asian J Trop Med Public Health; 2003 Oct; 34 Suppl 3():174-8. PubMed ID: 15906729
    [Abstract] [Full Text] [Related]

  • 8. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
    Cavarzere P, Samara-Boustani D, Flechtner I, Dechaux M, Elie C, Tardy V, Morel Y, Polak M.
    Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
    [Abstract] [Full Text] [Related]

  • 9. Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program.
    Cavarzere P, Camilot M, Teofoli F, Tatò L.
    Horm Res; 2005 Aug; 63(4):180-6. PubMed ID: 15818055
    [Abstract] [Full Text] [Related]

  • 10. Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.
    Lee JE, Moon Y, Lee MH, Jun YH, Oh KI, Choi JW.
    Ann Clin Lab Sci; 2008 Aug; 38(3):235-40. PubMed ID: 18715851
    [Abstract] [Full Text] [Related]

  • 11. Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia.
    Gatelais F, Berthelot J, Beringue F, Descamps P, Bonneau D, Limal JM, Coutant R.
    Pediatr Res; 2004 Nov; 56(5):701-5. PubMed ID: 15371568
    [Abstract] [Full Text] [Related]

  • 12. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
    Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, Holtkamp U, Sander J.
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2581-9. PubMed ID: 17456574
    [Abstract] [Full Text] [Related]

  • 13. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
    Kopacek C, de Castro SM, Prado MJ, da Silva CM, Beltrão LA, Spritzer PM.
    BMC Pediatr; 2017 Jan 17; 17(1):22. PubMed ID: 28095810
    [Abstract] [Full Text] [Related]

  • 14. The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns.
    Pearce M, Dauerer E, DiRienzo AG, Caggana M, Tavakoli NP.
    Eur J Pediatr; 2017 Jan 17; 176(1):121-129. PubMed ID: 27900477
    [Abstract] [Full Text] [Related]

  • 15. High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening.
    Castro PS, Rassi TO, Araujo RF, Pezzuti IL, Rodrigues AS, Bachega TASS, Silva IN.
    J Pediatr Endocrinol Metab; 2019 May 27; 32(5):499-504. PubMed ID: 31028712
    [Abstract] [Full Text] [Related]

  • 16. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
    Balsamo A, Cacciari E, Piazzi S, Cassio A, Bozza D, Pirazzoli P, Zappulla F.
    Pediatrics; 1996 Sep 27; 98(3 Pt 1):362-7. PubMed ID: 8784357
    [Abstract] [Full Text] [Related]

  • 17. [Neonatal screening for congenital adrenal hyperplasia in Shanghai areas].
    Gu X, Zhou J, Ye J.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan 27; 36(1):16-8. PubMed ID: 11955341
    [Abstract] [Full Text] [Related]

  • 18. Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience.
    González EC, Carvajal F, Frómeta A, Arteaga AL, Castells EM, Espinosa T, Coto R, Pérez PL, Tejeda Y, Del Río L, Segura MT, Almenares P, Robaina R, Fernández JL.
    Clin Chim Acta; 2013 Jun 05; 421():73-8. PubMed ID: 23481450
    [Abstract] [Full Text] [Related]

  • 19. Screening for congenital adrenal hyperplasia: the Delfia Screening Test overestimates serum 17-hydroxyprogesterone in preterm infants.
    al Saedi S, Dean H, Dent W, Stockl E, Cronin C.
    Pediatrics; 1996 Jan 05; 97(1):100-2. PubMed ID: 8545200
    [Abstract] [Full Text] [Related]

  • 20. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
    Seo JY, Park HD, Kim JW, Oh HJ, Yang JS, Chang YS, Park WS, Lee SY.
    J Perinat Med; 2014 Jan 05; 42(1):121-7. PubMed ID: 23989111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.